TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Bone Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Bone Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Bone Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Bone Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Bone Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Bone Drugs industry

Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALApr 10, 2025ASCENDIS PHARMA
Method For Preparing A Three-Dimensional Scaffold For Medical UseASKEL HEALTHCAREDec 23, 2024DOMPATENT VON KREISLER SELTING WERNER PARTNERSCHAFT VON PATENTANWALTEN UND RECHTSANWALTEN MBB
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 13, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024SANDOZ
Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsNUVAMIDMay 30, 2024SCHLICH
Product, In Particular Nutritional Supplement, Animal Feed, Foodstuff, Drug, Cosmetic And/Or Animal Feed Supplement For Supplying At Least One Molecule That Bonds To A Vitamin D Receptor, And Method For The Production ThereofBTERApr 12, 2024HERBONIS ANIMAL HEALTH
Composition For Injection Of Hyaluronic Acid, Containing Hyaluronic Acid Derivative And Dna Fraction, And Use ThereofBMI KOREAMar 6, 2024MASTELLI
Treatment Of Metabolic Disorders In Canine AnimalsBOEHRINGER INGELHEIM VETMEDICAFeb 9, 2024CEVA SANTE ANIMALE
Direct Compression Formulation And ProcessNOVARTISSep 11, 2023HERZOG PATENTANWALTS
A Concentrated Krill Protein Hydrolysate FractionRIMFROSTAug 29, 2023AKER BIOMARINE UNDERSTORY

To stay ahead in the competitive Bone Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Bone Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Mar 3, 2021Tofacitinib Oral Sustained Release Dosage FormsPFIZER6
Sep 1, 2021Direct Compression Formulation And ProcessNOVARTIS6
Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM PHARMA5
Oct 26, 2022Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MAB4
Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses ThereofCANTARGIA3
May 27, 2020Calcifediol Soft CapsulesFAES FARMA3
Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICAL3
Aug 2, 2017Method Of Increasing Bone Toughness And Stiffness And Reducing FracturesELI LILLY3
Mar 21, 2018Treatment Of Gout And HyperuricemiaARDEA BIOSCIENCES3
May 17, 2017A Stable Composition Comprising Pthrp And Uses ThereofRADIUS HEALTH2